Table 1.
Characteristics of all patients
| Item | Home care group (n = 94) | Hospital care group (n = 96) | P | Standardized difference |
|---|---|---|---|---|
| Gender (n, male/female) | 46/48 | 55/41 | 0.25 | 0.17 |
| Age (yr, mean ± SD) | 72.7 ± 13.9 | 69.3 ± 10.9 | 0.06 | 0.28 |
| Primary site (n) | 0.45 | |||
| Lung | 12 | 19 | 0.19 | |
| Stomach/esophagus | 31 | 30 | 0.04 | |
| Liver/biliary tract/pancreas | 25 | 23 | 0.06 | |
| Large intestine | 16 | 9 | 0.23 | |
| Breast | 2 | 4 | 0.12 | |
| Others | 8 | 11 | 0.10 | |
| Performance status (n) | 0.20 | |||
| 0 | 0 | 6 | 0.37 | |
| 1 | 13 | 23 | 0.26 | |
| 2 | 34 | 23 | 0.27 | |
| 3 | 39 | 32 | 0.17 | |
| 4 | 8 | 12 | 0.13 | |
| Use anti-cancer agents (n, used/unused)a | 3/91 | 3/93 | 1.00 | 0.004 |
aThis is about whether patients used anti-cancer agents or not from 1 month before referral to Palliative Care Team to death.